Behavioural and neurochemical alterations following acute inflammation induced by intraperitoneal and intratracheal injection with lipopolysaccharide in mice.

Anxiety Brain-derived neurotrophic factor Inflammation Lipopolysaccharide Lung Microglia

Journal

Naunyn-Schmiedeberg's archives of pharmacology
ISSN: 1432-1912
Titre abrégé: Naunyn Schmiedebergs Arch Pharmacol
Pays: Germany
ID NLM: 0326264

Informations de publication

Date de publication:
20 Sep 2024
Historique:
received: 24 06 2024
accepted: 30 08 2024
medline: 20 9 2024
pubmed: 20 9 2024
entrez: 20 9 2024
Statut: aheadofprint

Résumé

The persistent symptoms of anxiety, depression, and fatigue that follow severe acute respiratory syndrome coronavirus 2 infection and accompany pulmonary inflammation pose significant clinical challenges. However, the correlation between pulmonary inflammation and mental health remains unclear. This study sought to examine the effects of intratracheal injection of lipopolysaccharide (LPS), a bacterial endotoxin, on anxiety-like behaviour in a mouse model suffering with pulmonary inflammation. The reactions of these animal models to new environments were evaluated using light-dark box and hole-board tests as anxiety-inducing stimuli. Microglial responses were evaluated via immunohistochemistry, and serum concentrations of tumour necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) were measured. Both intraperitoneal and intratracheal injections of LPS induced anxiety-like behaviours, as indicated by the outcomes of the light-dark box and hole-board tests. Serum levels of TNF-α and IL-6 considerably increased following both injection routes. The protein levels of the 5-HT

Identifiants

pubmed: 39302421
doi: 10.1007/s00210-024-03423-x
pii: 10.1007/s00210-024-03423-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : JSPS KAKENHI
ID : JP23K14400
Organisme : JSPS KAKENHI
ID : JP22K06714

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

AbdoQaid EY, Abdullah Z, Zakaria R, Long I (2022) Minocycline attenuates lipopolysaccharide-induced locomotor deficit and anxiety-like behavior and related expression of the BDNF/CREB protein in the rat Medial Prefrontal Cortex (mPFC). Int J Mol Sci 23:13474
doi: 10.3390/ijms232113474
Al-Jassas HK, Al-Hakeim HK, Maes M (2022) Intersections between pneumonia, lowered oxygen saturation percentage and immune activation mediate depression, anxiety, and chronic fatigue syndrome-like symptoms due to COVID-19: a nomothetic network approach. J Affect Disorders 297:233–245
pubmed: 34699853 doi: 10.1016/j.jad.2021.10.039
Carola V, Frazzetto G, Pascucci T, Audero E, Puglisi-Allegra S, Cabib S, Lesch KP, Gross C (2008) Identifying molecular substrates in a mouse model of the serotonin transporter x environment risk factor for anxiety and depression. Biol Psychiatry 63:840–846
pubmed: 17949690 doi: 10.1016/j.biopsych.2007.08.013
Cazareth J, Guyon A, Heurteaux C, Chabry J, Petit-Paitel A (2014) Molecular and cellular neuroinflammatory status of mouse brain after systemic lipopolysaccharide challenge: importance of CCR2/CCL2 signaling. J Neuroinflammation 11:132
pubmed: 25065370 pmcid: 4237883 doi: 10.1186/1742-2094-11-132
Choubey P, Kwatra M, Pandey SN, Kumar D, Dwivedi DK, Rajput P, Mishra A, Lahkar M, Jangra A (2019) Ameliorative effect of fisetin against lipopolysaccharide and restraint stress-induced behavioral deficits via modulation of NF-kappaB and IDO-1. Psychopharmacology 236:741–752
pubmed: 30426184 doi: 10.1007/s00213-018-5105-3
Cibelli M, Fidalgo AR, Terrando N, Ma D, Monaco C, Feldmann M, Takata M, Lever IJ, Nanchahal J, Fanselow MS, Maze M (2010) Role of interleukin-1beta in postoperative cognitive dysfunction. Ann Neurol 68:360–368
pubmed: 20818791 pmcid: 4836445 doi: 10.1002/ana.22082
Couch Y, Xie Q, Lundberg L, Sharp T, Anthony DC (2015) A model of post-infection fatigue is associated with increased TNF and 5-HT2A receptor expression in mice. PLoS ONE 10:e0130643
pubmed: 26147001 pmcid: 4493081 doi: 10.1371/journal.pone.0130643
Duman RS, Monteggia LM (2006) A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59:1116–1127
pubmed: 16631126 doi: 10.1016/j.biopsych.2006.02.013
Henry CJ, Huang Y, Wynne A, Hanke M, Himler J, Bailey MT, Sheridan JF, Godbout JP (2008) Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. J Neuroinflammation 5:15
pubmed: 18477398 pmcid: 2412862 doi: 10.1186/1742-2094-5-15
Homberg JR, Molteni R, Calabrese F, Riva MA (2014) The serotonin-BDNF duo: developmental implications for the vulnerability to psychopathology. Neurosci Biobehav Rev 43:35–47
pubmed: 24704572 doi: 10.1016/j.neubiorev.2014.03.012
Hou Y, Xie G, Liu X, Li G, Jia C, Xu J, Wang B (2016) Minocycline protects against lipopolysaccharide-induced cognitive impairment in mice. Psychopharmacology 233:905–916
pubmed: 26645224 doi: 10.1007/s00213-015-4169-6
Izushi Y, Teshigawara K, Liu K, Wang D, Wake H, Takata K, Yoshino T, Takahashi HK, Mori S, Nishibori M (2016) Soluble form of the receptor for advanced glycation end-products attenuates inflammatory pathogenesis in a rat model of lipopolysaccharide-induced lung injury. J Pharmacol Sci 130:226–234
pubmed: 27038888 doi: 10.1016/j.jphs.2016.02.005
Kemp GM, Altimimi HF, Nho Y, Heir R, Klyczek A, Stellwagen D (2022) Sustained TNF signaling is required for the synaptic and anxiety-like behavioral response to acute stress. Mol Psychiatry 27:4474–4484
pubmed: 36104437 pmcid: 9734040 doi: 10.1038/s41380-022-01737-x
Kitamura Y, Akiyama K, Kitagawa K, Shibata K, Kawasaki H, Suemaru K, Araki H, Sendo T, Gomita Y (2008a) Chronic coadministration of carbamazepine together with imipramine produces antidepressant-like effects in an ACTH-induced animal model of treatment-resistant depression: involvement of 5-HT(2A) receptors? Pharmacol Biochem Behav 89:235–240
pubmed: 18255130 doi: 10.1016/j.pbb.2007.12.015
Kitamura Y, Fujitani Y, Kitagawa K, Miyazaki T, Sagara H, Kawasaki H, Shibata K, Sendo T, Gomita Y (2008b) Effects of imipramine and bupropion on the duration of immobility of ACTH-treated rats in the forced swim test: involvement of the expression of 5-HT2A receptor mRNA. Biol Pharm Bull 31:246–249
pubmed: 18239281 doi: 10.1248/bpb.31.246
Kitamura Y, Shibata K, Akiyama K, Kimoto S, Fujitani Y, Kitagawa K, Kanzaki H, Ouchida M, Shimizu K, Kawasaki H, Sendo T, Gomita Y (2008c) Increased DOI-induced wet-dog shakes in adrenocorticotropic hormone-treated rats are not affected by chronic imipramine treatment: possible involvement of enhanced 5-HT(2A)-receptor expression in the frontal cortex. J Pharmacol Sci 106:100–106
pubmed: 18187923 doi: 10.1254/jphs.FP0071615
Kitamura Y, Hattori S, Yoneda S, Watanabe S, Kanemoto E, Sugimoto M, Kawai T, Machida A, Kanzaki H, Miyazaki I, Asanuma M, Sendo T (2015) Doxorubicin and cyclophosphamide treatment produces anxiety-like behavior and spatial cognition impairment in rats: Possible involvement of hippocampal neurogenesis via brain-derived neurotrophic factor and cyclin D1 regulation. Behav Brain Res 292:184–193
pubmed: 26057360 doi: 10.1016/j.bbr.2015.06.007
Kitamura Y, Hongo S, Yamashita Y, Yagi S, Otsuki K, Miki A, Okada A, Ushio S, Esumi S, Sendo T (2019) Influence of lipopolysaccharide on diazepam-modified loss of righting reflex duration by pentobarbital treatment in mice. Eur J Pharmacol 842:231–238
pubmed: 30391741 doi: 10.1016/j.ejphar.2018.10.049
Lan T, Wu Y, Zhang Y, Li S, Zhu Z, Wang L, Mao X, Li Y, Fan C, Wang W, Yu SY (2022) Agomelatine rescues lipopolysaccharide-induced neural injury and depression-like behaviors via suppression of the Galphai-2-PKA-ASK1 signaling pathway. J Neuroinflammation 19:117
pubmed: 35610704 pmcid: 9131561 doi: 10.1186/s12974-022-02479-x
Leng F, Edison P (2021) Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol 17:157–172
pubmed: 33318676 doi: 10.1038/s41582-020-00435-y
Liu LR, Liu JC, Bao JS, Bai QQ, Wang GQ (2020) Interaction of microglia and astrocytes in the neurovascular unit. Front Immunol 11:1024
pubmed: 32733433 pmcid: 7362712 doi: 10.3389/fimmu.2020.01024
Mallik SB, Mudgal J, Kinra M, Hall S, Grant GD, Anoopkumar-Dukie S, Nampoothiri M, Zhang Y, Arora D (2023) Involvement of indoleamine 2, 3-dioxygenase (IDO) and brain-derived neurotrophic factor (BDNF) in the neuroprotective mechanisms of ferulic acid against depressive-like behaviour. Metab Brain Dis 38:2243–2254
pubmed: 37490224 pmcid: 10504153 doi: 10.1007/s11011-023-01267-7
Matsumoto D, Ushio S, Wada Y, Noda Y, Esumi S, Izushi Y, Kitamura Y, Sendo T (2021) Bumetanide prevents diazepam-modified anxiety-like behavior in lipopolysaccharide-treated mice. Eur J Pharmacol 904:174195
pubmed: 34004209 doi: 10.1016/j.ejphar.2021.174195
Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, Hlh across speciality collaboration UK (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395:1033–1034
pubmed: 32192578 pmcid: 7270045 doi: 10.1016/S0140-6736(20)30628-0
Miyao M, Hirotsu A, Tatsumi K, Tanaka T (2023) Prior exposure to stress exacerbates neuroinflammation and causes long-term behavior changes in sepsis. Heliyon 9:e16904
pubmed: 37484359 pmcid: 10360945 doi: 10.1016/j.heliyon.2023.e16904
Nakamura Y, Kitamura Y, Sumiyoshi Y, Naito N, Kan S, Ushio S, Miyazaki I, Asanuma M, Sendo T (2018) Involvement of 5-HT(2A) receptor hyperfunction in the anxiety-like behavior induced by doxorubicin and cyclophosphamide combination treatment in rats. J Pharmacol Sci 138:192–197
pubmed: 30360947 doi: 10.1016/j.jphs.2018.10.001
Needham MJ, Webb CE, Bryden DC (2017) Postoperative cognitive dysfunction and dementia: what we need to know and do. Br J Anaesth 119:i115–i125
pubmed: 29161395 doi: 10.1093/bja/aex354
Nishitsuji K, To H, Murakami Y, Kodama K, Kobayashi D, Yamada T, Kubo C, Mine K (2004) Tandospirone in the treatment of generalised anxiety disorder and mixed anxiety-depression : results of a comparatively high dosage trial. Clin Drug Investig 24:121–126
pubmed: 17516698 doi: 10.2165/00044011-200424020-00007
O’Connor JC, Lawson MA, Andre C, Moreau M, Lestage J, Castanon N, Kelley KW, Dantzer R (2009) Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry 14:511–522
pubmed: 18195714 doi: 10.1038/sj.mp.4002148
Pelaia C, Tinello C, Vatrella A, De Sarro G, Pelaia G (2020) Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications. Ther Adv Respir Dis 14:1753466620933508
pubmed: 32539627 pmcid: 7298425 doi: 10.1177/1753466620933508
Pencea V, Bingaman KD, Wiegand SJ, Luskin MB (2001) Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, septum, thalamus, and hypothalamus. J Neurosci Off J Soc Neuroscie 21:6706–6717
doi: 10.1523/JNEUROSCI.21-17-06706.2001
Polter AM, Li X (2010) 5-HT1A receptor-regulated signal transduction pathways in brain. Cell Signal 22:1406–1412
pubmed: 20363322 pmcid: 2903656 doi: 10.1016/j.cellsig.2010.03.019
Sabedra Sousa FS, Birmann PT, Bampi SR, Fronza MG, Balaguez R, Alves D, Leite MR, Nogueira CW, Bruning CA, Savegnago L (2019) Lipopolysaccharide-induced depressive-like, anxiogenic-like and hyperalgesic behavior is attenuated by acute administration of alpha-(phenylselanyl) acetophenone in mice. Neuropharmacology 146:128–137
pubmed: 30468797 doi: 10.1016/j.neuropharm.2018.11.028
Schinder AF, Berninger B, Poo M (2000) Postsynaptic target specificity of neurotrophin-induced presynaptic potentiation. Neuron 25:151–163
pubmed: 10707980 doi: 10.1016/S0896-6273(00)80879-X
Staron J, Bugno R, Hogendorf AS, Bojarski AJ (2018) 5-HT1A receptor ligands and their therapeutic applications: review of new patents. Expert Opin Ther Pat 28:679–689
pubmed: 30124346 doi: 10.1080/13543776.2018.1514011
Sulakhiya K, Keshavlal GP, Bezbaruah BB, Dwivedi S, Gurjar SS, Munde N, Jangra A, Lahkar M, Gogoi R (2016) Lipopolysaccharide induced anxiety- and depressive-like behaviour in mice are prevented by chronic pre-treatment of esculetin. Neurosci Lett 611:106–111
pubmed: 26620836 doi: 10.1016/j.neulet.2015.11.031
Takao K, Nagatani T, Kitamura Y, Kawasaki K, Hayakawa H, Yamawaki S (1995) Chronic forced swim stress of rats increases frontal cortical 5-HT2 receptors and the wet-dog shakes they mediate, but not frontal cortical beta-adrenoceptors. Eur J Pharmacol 294:721–726
pubmed: 8750738 doi: 10.1016/0014-2999(95)00620-6
Takao K, Nagatani T, Kitamura Y, Yamawaki S (1997) Effects of corticosterone on 5-HT1A and 5-HT2 receptor binding and on the receptor-mediated behavioral responses of rats. Eur J Pharmacol 333:123–128
pubmed: 9314024 doi: 10.1016/S0014-2999(97)01126-6
Tang L, Li S, Yu J, Zhang Y, Yang L, Tong D, Xu J (2022) Nonylphenol induces anxiety-like behavior in rats by regulating BDNF/TrkB/CREB signal network. Food Chem Toxicol 166:113197
Ushio S, Wada Y, Nakamura M, Matsumoto D, Hoshika K, Shiromizu S, Iwata N, Esumi S, Kajizono M, Kitamura Y, Sendo T (2022) Anxiolytic-like effects of hochuekkito in lipopolysaccharide-treated mice involve interleukin-6 inhibition. Front Pharmacol 13:890048
pubmed: 36034871 pmcid: 9411515 doi: 10.3389/fphar.2022.890048
Wang X, Hu D, Zhang L, Lian G, Zhao S, Wang C, Yin J, Wu C, Yang J (2014) Gomisin A inhibits lipopolysaccharide-induced inflammatory responses in N9 microglia via blocking the NF-kappaB/MAPKs pathway. Food Chem Toxicol 63:119–127
pubmed: 24211520 doi: 10.1016/j.fct.2013.10.048
Weisstaub NV, Zhou M, Lira A, Lambe E, Gonzalez-Maeso J, Hornung JP, Sibille E, Underwood M, Itohara S, Dauer WT, Ansorge MS, Morelli E, Mann JJ, Toth M, Aghajanian G, Sealfon SC, Hen R, Gingrich JA (2006) Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science 313:536–540
pubmed: 16873667 doi: 10.1126/science.1123432

Auteurs

Yasuhisa Izushi (Y)

Department of Pharmacotherapy, School of Pharmacy, Shujitsu University, 1-6-1 Nishigawara, Naka-Ku, Okayama, 703-8516, Japan.

Shouki Tanaka (S)

Department of Pharmacotherapy, School of Pharmacy, Shujitsu University, 1-6-1 Nishigawara, Naka-Ku, Okayama, 703-8516, Japan.

Teppei Ueda (T)

Department of Pharmacotherapy, School of Pharmacy, Shujitsu University, 1-6-1 Nishigawara, Naka-Ku, Okayama, 703-8516, Japan.

Soichiro Ushio (S)

Department of Emergency and Disaster Medical Pharmacy, Faculty of Pharmaceutical Sciences, Fukuoka University, 8-19-1 Nanakuma, Jyonan-Ku, Fukuoka, 814-0133, Japan.

Yuichi Tasaka (Y)

Department of Clinical Pharmacy, School of Pharmacy, Shujitsu University, 1-6-1 Nishigawara, Naka-Ku, Okayama, 703-8516, Japan.

Ikuko Miyazaki (I)

Department of Medical Neurobiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-Cho, Okayama, 700-8558, Japan.

Masato Asanuma (M)

Department of Medical Neurobiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-Cho, Okayama, 700-8558, Japan.

Yoshihisa Kitamura (Y)

Department of Pharmacotherapy, School of Pharmacy, Shujitsu University, 1-6-1 Nishigawara, Naka-Ku, Okayama, 703-8516, Japan. kitamu-y@shujitsu.ac.jp.

Classifications MeSH